As per a report released by the the Louisiana court, lawsuits against the blockbuster blood thinner xarelto drug manufacturers, Xarelto have now reached 9,000 across the country. The lawsuits are in process regarding Xarelto and according to the report all the Xarelto lawsuits will be consolidated for multidistrict litigation. About 1,000 cases have also been filed in Pennsylvania and another 1,000 in Delaware. The most of the lawsuits were filed against its manufacturers, Janssen Pharmaceuticals and Bayer AG alleging that these companies failed to warn patients and physicians of the increased risks of fatal internal bleeding when using Xarelto. The four bellwether cases that have been selected scheduled to begin in early 2017 in Louisiana, Mississippi, and Texas; these cases could set the tone for future Xarelto lawsuits.
Xarelto (Rivaroxaban) is an FXa inhibitor indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for extended risk reduction. The blood thinner is manufactured by Bayer and is marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. Xarelto was initially approved in 2011 and is one of the most recent blood thinners on the market. Xarelto medication is mostly prescribed to the patients who were gone through hip and knee replacement surgeries. It generally is prescribed as an alternative to warfarin (Coumadin), a blood thinner that began to be used in 1954. The patients took Xarelto to treat them from atrial fibrillation (irregular heart rhythm), hypertension, or other valvular heart conditions. The patients took Xarelto to treat them from atrial fibrillation (irregular heart rhythm), hypertension, or other valvular heart conditions.
Recently the US Food and Drug Administration has decline the approval of Portola Pharmaceuticals’ (NASDAQ: PTLA) anticoagulant antidote product for uncontrolled bleeding linked to blood thinners including Xarelto (rivaroxaban) and Eliquis (apixaban). Xarelto associated with severe adverse events include internal bleeding, fatal brain and stomach bleeds. There is allegedly no antidote to stop uncontrolled bleeding, which can lead Xarelto to cause someone to bleed to death. In addition, important information about the lack of an antidote was buried within the prescribing information. Plaintiffs alleges that manufacturers withheld information about the lack of an antidote along with the prescribing information and they claims that if the company had warned of the risks, then patients would have been prescribed the drug warfarin, a medication in which internal bleeding can be treated with dosages of Vitamin K.
Xarelto has been used by more than 9,000,000 people around the world and it is associated with severe health complications. The number of lawsuit filed from all over the nation alleges that the manufacturers Bayer and Janssen knew or should have known of the risks associated with the drug. The manufactures have to break their silence and reveal the risk linked with the drug. If you or your love ones are facing fatal complication due to real brad of Xarelto can take a legal action against the company. He/she can claim for reimbursement money against complication or loss within limited period of time. We look forward to fighting for the rights of our clients. We have an experience attorneys group who evaluate your case free of cost unless we win the case for you. Contact Drugsclaim.com for free case review.